Table 4 Characteristics of patients with definite and probable stent thrombosis
Case | Risk factors | Lesions | Stent number | AA-MAR, % | ADP-MAR, % | CYP2C19 gene | Use of antiplatelet drugs | Time from PCI to stent thrombosis (days) | Cardiac death |
|---|---|---|---|---|---|---|---|---|---|
1 | EH | Multi-vessel disease | 2 | 15.4 | 60.6 | NA | Dual-antiplatelet for 2 years | 2 | 0 |
2 | Smoking | Left main lesion | 3 | 42.9 | 60.3 | NA | Dual-antiplatelet for 2 years | 241 | 1 |
3 | EH, DM, smoking | Multi-vessel disease | 8 | 35 | 58.4 | Poor metabolizer | Dual-antiplatelet for 2 years | 170 | 0 |
4 | EH, smoking | Multi-vessel disease | 3 | 20 | 58.6 | NA | Dual-antiplatelet for 2 years | 1 | 0 |
5 | DM | Multi-vessel disease | 3 | 79.8 | 67.9 | NA | Clopidogrel for lifelong time, aspirin for half year | 236 | 1 |
6 | EH, smoking | Pro-LAD lesion | 1 | 50 | 60.5 | Intermediate metabolizer | Clopidogrel for 1 year, aspirin stopped by oneself at 1 month after procedure, and aspirin re-used at 1 year | 455 | 0 |
7 | EH | Multi-vessel disease | 3 | 20.2 | 63 | Intermediate metabolizer | Aspirin for lifelong time, clopidogrel for 1 year | 12 | 0 |
8 | EH, DM | Multi-vessel disease | 2 | 39 | 58.7 | Intermediate metabolizer | Dual-antiplatelet for 2 years | 82 | 0 |
9 | No | Multi-vessel disease + left main lesion | 3 | 49.8 | 61.1 | NA | Dual-antiplatelet for 2 years | 94 | 1 |
10 | EH, DM | Multi-vessel disease + left main lesion | 6 | 37 | 45 | Poor metabolizer | Dual-antiplatelet for 2 years | 1 | 0 |
11 | DM, smoking | Multi-vessel disease | 4 | 24.6 | 56.4 | Poor metabolizer | Dual-antiplatelet for 2 years | 731 | 1 |
12 | EH, DM, smoking, CKD 4 | Multi-vessel disease + left main lesion | 7 | 21.1 | 68 | Intermediate metabolizer | Dual-antiplatelet for 2 years | 617 | 1 |
13 | Smoking | Multi-vessel disease | 2 | 34.6 | 57.2 | Intermediate metabolizer | Dual-antiplatelet for 2 years | 42 | 1 |
14 | EH | Multi-vessel disease | 6 | 45.4 | 60.3 | Intermediate metabolizer | Dual-antiplatelet for 2 years | 138 | 1 |